Thermo Fisher Scientific (TMO) Price to Earnings (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Price to Earnings for 18 consecutive years, with 107.96 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings rose 13.24% year-over-year to 107.96; the trailing twelve-month figure through Jun 2026 stood at 26.94 (up 15.07% YoY), and the FY2025 full-year result was 31.84, up 2.77% from the prior year.
• Price to Earnings improved to 107.96 in Q2 2026 per TMO's latest filing, from 105.72 in the prior quarter.
• Across five years, Price to Earnings topped out at 172.47 in Q2 2023 and bottomed at 95.34 in Q2 2025.
• Historically, Price to Earnings has averaged 125.82 across 5 years, with a median of 124.73 in 2023.
• The sharpest annual moves came in 2023 and 2025: Price to Earnings soared 64.75% in 2023, then tumbled 30.13% in 2025.
• Over 5 years, Price to Earnings stood at 134.68 in 2022, then fell by 7.8% to 124.17 in 2023, then retreated by 13.63% to 107.25 in 2024, then grew by 0.36% to 107.63 in 2025, then climbed by 0.31% to 107.96 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 107.96, 105.72, and 107.63 for Q2 2026, Q1 2026, and Q4 2025 respectively.